Monitoring cellular immune markers in HIV infection: from activation to exhaustion

Current Opinion in HIV and AIDS

Volumn 8, Issue 2, 2013, Pages 125-131

  Sauce, Delphine ^a   Elbim, Carole ^a   Appay, Victor ^a  

^a INSERM   (France)

Author keywords

exhaustion; function; immune activation; lymphocytes; phenotype

Indexed keywords

B LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE FUNCTION TEST; INFLAMMATION; MACROPHAGE; NATURAL KILLER CELL; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; REVIEW;

BIOLOGICAL MARKERS; HIV; HIV INFECTIONS; HUMANS; MONITORING, IMMUNOLOGIC;

EID: 84873446224     PISSN: 1746630X     EISSN: 17466318     Source Type: Journal    
DOI: 10.1097/COH.0b013e32835d08a9     Document Type: Review

References (79)

1. Brenchley JM, Schacker TW, Ruff LE, et al. CD4 T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract. J Exp Med 2004; 200:749-759.
2. Okoye A, Meier-Schellersheim M, Brenchley JM, et al. Progressive CD4 central memory T cell decline results in CD4 effector memory insufficiency and overt disease in chronic SIV infection. J Exp Med 2007; 204:2171-2185.
3. Pandrea I, Apetrei C, Gordon S, et al. Paucity of CD4CCR5 T cells is a typical feature of natural SIV hosts. Blood 2007; 109:1069-1076.
4. Paiardini M, Cervasi B, Reyes-Aviles E, et al. Low levels of SIV infection in sooty mangabey central memory CD4 T cells are associated with limited CCR5 expression. Nat Med 2011; 17:830-836.
5. Letvin NL,Mascola JR, Sun Y, et al. PreservedCD4centralmemory T cells and survival in vaccinated SIV-challenged monkeys. Science 2006; 312:1530-1533.
6. Descours B, Avettand-Fenoel V, Blanc C, et al. Immune responses driven by protective human leukocyte antigen alleles from long-term nonprogressors are associated with low HIV reservoir in central memory CD4 T cells. Clin Infect Dis 2012; 54:1495-1503.
7. van Grevenynghe J, Procopio FA, He Z, et al. Transcription factor FOXO3a controls the persistence of memory CD4 T cells during HIV infection. Nat Med 2008; 14:266-274.
8. Alter G, Heckerman D, Schneidewind A, et al. HIV-1 adaptation to NK-cellmediated immune pressure. Nature 2011; 476:96-100.
9. Appay V, Sauce D. Immune activation and inflammation in HIV-1 infection: causes and consequences. J Pathol 2008; 214:231-241.
10. Deeks SG. HIV infection, inflammation, immunosenescence, and aging. Annu Rev Med 2011; 62:141-155.
11. Hunt PW. HIV and inflammation: mechanisms and consequences. Curr HIV/AIDS Rep 2012; 9:139-147.
12. Lanier LL. Up on the tightrope: natural killer cell activation and inhibition. Nat Immunol 2008; 9:495-502.
13. Altfeld M, Fadda L, Frleta D, Bhardwaj N. DCs and NK cells: critical effectors in the immune response to HIV-1. Nat Rev Immunol 2011; 11:176-186.
14. Martin MP, Gao X, Lee JH, et al. Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDS. Nat Genet 2002; 31:429-434.
15. Alter G, Martin MP, Teigen N, et al. Differential natural killer cell-mediated inhibition of HIV-1 replication based on distinct KIR/HLA subtypes. J Exp Med 2007; 204:3027-3036.
16. Long BR, Ndhlovu LC, Oksenberg JR, et al. Conferral of enhanced natural killer cell function by KIR3DS1 in early human immunodeficiency virus type 1 infection. J Virol 2008; 82:4785-4792.
17. Johansson SE, Rollman E, Chung AW, et al. NK cell function and antibodies mediating ADCC in HIV-1-infected viremic and controller patients. Viral Immunol 2011; 24:359-368.
18. Lambotte O, Ferrari G, Moog C, et al. Heterogeneous neutralizing antibody and antibody-dependent cell cytotoxicity responses in HIV-1 elite controllers. Aids 2009; 23:897-906.
19. Richman DD, Wrin T, Little SJ, Petropoulos CJ. Rapid evolution of the neutralizing antibody response to HIV type 1 infection. Proc Natl Acad Sci USA 2003; 100:4144-4149.
20. Stamatatos L, Morris L, Burton DR, Mascola Jr. Neutralizing antibodies generated during natural HIV-1 infection: Good news for an HIV-1 vaccine? Nat Med 2009; 15:866-870.
21. Alam SM, Scearce RM, Parks RJ, et al. Human immunodeficiency virus type 1 gp41 antibodies that mask membrane proximal region epitopes: Antibody binding kinetics, induction, and potential for regulation in acute infection. J Virol 2008; 82:115-125.
22. Wilson PC, Andrews SF. Tools to therapeutically harness the human antibody response. Nat Rev Immunol 2012; 12:709-719.
23. Franz B, May KF Jr, Dranoff G, Wucherpfennig K. Ex vivo characterization and isolation of rare memory B cells with antigen tetramers. Blood 2011; 118:348-357.
24. Crotty S. Follicular helper CD4 T cells (TFH). Annu Rev Immunol 2011; 29:621-663.
25. Lindqvist M, van Lunzen J, Soghoian DZ, et al. Expansion of HIV-specific T follicular helper cells in chronic HIV infection. J Clin Invest 2012; 122:3271-3280.
26. Petrovas C, Yamamoto T, Gerner MY, et al. CD4 T follicular helper cell dynamics during SIV infection. J Clin Invest 2012; 122:3281-3294.
27. Appay V, Zaunders JJ, Papagno L, et al. Characterization of CD4() CTLs ex vivo. J Immunol 2002; 168:5954-5958.
28. Zheng N, Fujiwara M, Ueno T, et al. Strong ability of Nef-specific CD4 cytotoxic T cells to suppress human immunodeficiency virus type 1 (HIV-1) replication in HIV-1-infected CD4 T cells and macrophages. J Virol 2009; 83:7668-7677.
29. Soghoian DZ, Jessen H, Flanders M, et al. HIV-specific cytolytic CD4 T cell responses during acute HIV infection predict disease outcome. Sci Transl Med 2012; 4:123ra125.
30. Migueles SA, Osborne CM, Royce C, et al. Lytic granule loading of CD8 T cells is required for HIV-infected cell elimination associated with immune control. Immunity 2008; 29:1009-1021.
31. Saez-Cirion A, Lacabaratz C, Lambotte O, et al. HIV controllers exhibit potent CD8 T cell capacity to suppress HIV infection ex vivo and peculiar cytotoxic T lymphocyte activation phenotype. Proc Natl Acad Sci USA 2007; 104:6776-6781.
32. Hersperger AR, Pereyra F, Nason M, et al. Perforin expression directly ex vivo by HIV-specific CD8 T-cells is a correlate of HIV elite control. PLoS Pathog 2010; 6:e1000917.
33. Hersperger AR, Martin JN, Shin LY, et al. Increased HIV-specific CD8 T-cell cytotoxic potential in HIV elite controllers is associated with T-bet expression. Blood 2011; 117:3799-3808.
34. Almeida JR, Sauce D, Price DA, et al. Antigen sensitivity is a major determinant of CD8 T-cell polyfunctionality and HIV-suppressive activity. Blood 2009; 113:6351-6360.
35. Larsen M, Sauce D, Arnaud L, et al. Evaluating cellular polyfunctionality with a novel polyfunctionality index. PloS one 2012; 7:e42403.
36. Burton CT, Westrop SJ, Eccles-James I, et al. Altered phenotype of regulatory T cells associated with lack of human immunodeficiency virus (HIV)-1-specific suppressive function. Clin Exp Immunol 2011; 166:191-200.
37. Cummings JS, Cairo C, Armstrong C, et al. Impacts of HIV infection on Vgamma2Vdelta2 T cell phenotype and function: A mechanism for reduced tumor immunity in AIDS. J Leukoc Biol 2008; 84:371-379.
38. Hartigan-O'Connor DJ, Hirao LA, McCune JM, Dandekar S. Th17 cells and regulatory T cells in elite control over HIV and SIV. Curr Opin HIV AIDS 2011; 6:221-227.
39. Li D, Chen J, Jia M, et al. Loss of balance between T helper type 17 and regulatory T cells in chronic human immunodeficiency virus infection. Clin Exp Immunol 2011; 165:363-371.
40. Li D, Xu XN. NKT cells in HIV-1 infection. Cell Res 2008; 18:817-822.
41. Rallon NI, Lopez M, Soriano V, et al. Level, phenotype and activation status of CD4FoxP3 regulatory T cells in patients chronically infected with human immunodeficiency virus and/or hepatitis C virus. Clin Exp Immunol 2009; 155:35-43.
42. Vasan S, Tsuji M. A double-edged sword: The role of NKT cells in malaria and HIV infection and immunity. Semin Immunol 2010; 22:87-96.
43. d'Ettorre G, Paiardini M, Ceccarelli G, et al. HIV-associated immune activation: from bench to bedside. AIDS Res Hum Retroviruses 2011; 27:355-364.
44. Dutertre CA, Amraoui S, Derosa A, et al. Pivotal role of M-DC8 monocytes from viremic HIV-infected patients in TNF alpha overproduction in response to microbial products. Blood 2012; 120:2259-2268.
45. Stary G, Klein I, Kohlhofer S, et al. Plasmacytoid dendritic cells express TRAIL and induce CD4 T-cell apoptosis in HIV-1 viremic patients. Blood 2009; 114:3854-3863.
46. Sivaraman V, Zhang L, Su L. Type I interferon contributes to CD4 T cell depletion induced by infection with HIV-1 in the human thymus. J Virol 2011; 85:9243-9246.
47. Donhauser N, Pritschet K, Helm M, et al. Chronic immune activation in HIV-1 infection contributes to reduced interferon alpha production via enhanced CD40:CD40 ligand interaction. PloS One 2012; 7:e33925.
48. Barblu L, Machmach K, Gras C, et al. Plasmacytoid dendritic cells (pDCs) from HIV controllers produce interferon-alpha and differentiate into functional killer pDCs under HIV activation. J Infect Dis 2012; 206:790-801.
49. Favre D, Mold J, Hunt PW, et al. Tryptophan catabolism by indoleamine 2,3-dioxygenase 1 alters the balance of TH17 to regulatory T cells in HIV disease. Sci Transl Med 2010; 2:32ra36.
50. He Y, Li J, Zheng Y, et al. A randomized case-control study of dynamic changes in peripheral blood Th17/Treg cell balance and interleukin-17 levels in highly active antiretroviral-treated HIV type 1/AIDS patients. AIDS Res Hum Retroviruses 2012; 28:339-345.
51. Brenchley JM, Price Da, Schacker TW, et al. Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat Med 2006; 12:1365-1371.
52. Jiang W, Lederman MM, Hunt P, et al. Plasma levels of bacterial DNA correlate with immune activation and themagnitude of immune restoration in persons with antiretroviral-treated HIV infection. J Infect Dis 2009; 199:1177-1185.
53. Mavigner M, Cazabat M, Dubois M, et al. Altered CD4 T cell homing to the gut impairs mucosal immune reconstitution in treated HIV-infected individuals. J Clin Invest 2012; 122:62-69.
54. Guillot-Delost M, Le Gouvello S, Mesel-Lemoine M, et al. Human CD90 identifies Th17/Tc17 T cell subsets that are depleted in HIV-infected patients. J Immunol 2012; 188:981-991.
55. Sandler NG, Wand H, Roque A, et al. Plasma levels of soluble CD14 independently predict mortality in HIV infection. J Infect Dis 2011; 203:780-790.
56. Ancuta P, Weiss L, Haeffner-Cavaillon N. CD14CD16 cells derived in vitro from peripheral blood monocytes exhibit phenotypic and functional dendritic cell-like characteristics. Eur J Immunol 2000; 30:1872-1883.
57. Pulliam L, Gascon R, Stubblebine M, et al. Unique monocyte subset in patients with AIDS dementia. Lancet 1997; 349:692-695.
58. Hansel A, Gunther C, Ingwersen J, et al. Human slan (6-sulfo LacNAc) dendritic cells are inflammatory dermal dendritic cells in psoriasis and drive strong TH17/TH1 T-cell responses. J Allergy Clin Immunol 2012; 127:787-794; e781-e789.
59. Oliveira BF, Nogueira-Machado JA, Chaves MM. The role of oxidative stress in the aging process. SciWorld J 2010; 10:1121-1128.
60. Sachdeva M, Fischl MA, Pahwa R, et al. Immune exhaustion occurs concomitantly with immune activation and decrease in regulatory T cells in viremic chronically HIV-1-infected patients. J Acquir Immune Defic Syndr 2010; 54:447-454.
61. Sauce D, Almeida JR, Larsen M, et al. PD-1 expression on human CD8 T cells depends on both state of differentiation and activation status. Aids 2007; 21:2005-2013.
62. Khaitan A, Unutmaz D. Revisiting immune exhaustion during HIV infection. Curr HIV/AIDS Rep 2011; 8:4-11.
63. Peretz Y, He Z, Shi Y, et al. CD160 and PD-1 co-expression on HIV-specific CD8 T cells defines a subset with advanced dysfunction. PLoS Pathog 2012; 8:e1002840.
64. Yamamoto T, Price DA, Casazza JP, et al. Surface expression patterns of negative regulatory molecules identify determinants of virus-specific CD8 T-cell exhaustion in HIV infection. Blood 2011; 117:4805-4815.
65. Dyavar Shetty R, Velu V, Titanji K, et al. PD-1 blockade during chronic SIV infection reduces hyperimmune activation and microbial translocation in rhesus macaques. J Clin Invest 2012; 122:1712-1716.
66. Velu V, Titanji K, Zhu B, et al. Enhancing SIV-specific immunity in vivo by PD-1 blockade. Nature 2009; 458:206-210.
67. Boliar S, Murphy MK, Tran TC, et al. B-lymphocyte dysfunction in chronic HIV-1 infection does not prevent cross-clade neutralization breadth. J Virol 2012; 86:8031-8040.
68. Moir S, Ho J,Malaspina A, et al. Evidence for HIV-associated B cell exhaustion in a dysfunctional memory B cell compartment in HIV-infected viremic individuals. J Exp Med 2008; 205:1797-1805.
69. Kardava L, Moir S, Wang W, et al. Attenuation of HIV-associated human B cell exhaustion by siRNA downregulation of inhibitory receptors. J Clin Invest 2011; 121:2614-2624.
70. Papagno L, Spina CA, Marchant A, et al. Immune activation and CD8 T-cell differentiation towards senescence in HIV-1 infection. PLoS Biol 2004; 2:E20.
71. Roederer M, Dubs JG, And ersonMT, et al. CD8 naive T cell counts decrease progressively in HIV-infected adults. J Clin Invest 1995; 95:2061-2066.
72. Appay V, Fastenackels S, Katlama C, et al. Old age and anticytomegalovirus immunity are associated with altered T-cell reconstitution in HIV-1-infected patients. Aids 2011; 25:1813-1822.
73. Moir S, Malaspina A, Ogwaro KM, et al. HIV-1 induces phenotypic and functional perturbations of B cells in chronically infected individuals. Proc Natl Acad Sci USA 2001; 98:10362-10367.
74. Moir S, Malaspina A, Pickeral OK, et al. Decreased survival of B cells of HIV-viremic patients mediated by altered expression of receptors of the TNF superfamily. J Exp Med 2004; 200:587-599.
75. Fogli M, Torti C, Malacarne F, et al. Emergence of exhausted B cells in asymptomatic HIV-1-infected patients naive for HAART is related to reduced immune surveillance. Clin Dev Immunol 2012; 2012:829584.
76. Vieillard V, Fausther-Bovendo H, Samri A, Debre P. Specific phenotypic and functional features of natural killer cells from HIV-infected long-term nonprogressors and HIV controllers. J Acquir Immune Defic Syndr 2012; 53:564-573.
77. Sauce D, Larsen M, Fastenackels S, et al. HIV disease progression despite suppression of viral replication is associated with exhaustion of lymphopoiesis. Blood 2011; 117:5142-5151.
78. Carter CC, Onafuwa-Nuga A, McNamara LA, et al. HIV-1 infects multipotent progenitor cells causing cell death and establishing latent cellular reservoirs. Nat Med 2010; 16:446-451.
79. Moses AV, Williams S, Heneveld ML, et al. Human immunodeficiency virus infection of bone marrow endothelium reduces induction of stromal hematopoietic growth factors. Blood 1996; 87:919-925.